CSI Market
Sign In | Register

Amicus Therapeutics inc (FOLD) Quarterly Income Statement

Quarterly · GAAP · USD millions
Access FOLD Annual Income Statement →
By examining income statement figures across successive periods, users can identify shifts in Amicus Therapeutics inc's profitability and expense structure.
View historic periods: Download as CSV:
Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.
Quarterly Report, GAAP in USD millions
ITEM 		(Dec 31 2025)
Q4 2025 		(Sep 30 2025) (Jun 30 2025) (Mar 31 2025) (Dec 31 2024)
Revenues
Revenue From Contract With Customer Excluding Assessed Tax185.21
Total Revenue185.21
Costs & Expenses
Cost of Goods and Services Sold27.00
Gross Profit158.67
Selling, Administration, Marketing117.08
Depreciation & Amortization1.90
Research and Development Expense (Excluding Acquired in Process Cost)23.74
Asset Impairment Charges0.00
Other Operating Expense / -Income0.00
Total operating costs including COS169.72
Operating income / -loss15.95
Interest Expense0.00
Interest Expense, Borrowings0.00
Net Interest Expense / -Income0.00
Investment Income, Interest2.49
Other loss / -income-12.83
Total costs & expenses182.52
Income & Taxes
Income / -loss before income taxes3.14
Income taxes expenses / -benefit1.45
Income after income taxes1.69
Net income / -loss of other equity0.00
Income / -loss from continuing operations1.69
Net income / -loss1.69
Income / -loss to shareholder1.69
EBIT3.14
EBITD5.04
EBITDA5.72
Earnings Per Share
Basic EPS (excl. extra items)0.01
Basic Net EPS0.01
Basic shares outstanding (Mill. of Units)308.36
Diluted Net EPS0.01
Diluted average shares (Mill. of Units)308.36
4 historic quarters locked

Sign in to unlock the full Amicus Therapeutics inc income statement history.

Sign In Create Free Account

About Amicus Therapeutics Inc Quarterly Income Statement

What this statement shows

This page presents issuer-reported income statement data, detailing revenue, operating costs, expenses, and earnings as disclosed in SEC 10-Q filings and standardized by CSIMarket. The income statement reflects operating performance over a reporting period rather than financial position at a single date.

Revenue and expense treatment

Revenue and expense items are aligned to support period-to-period comparability. Operating and non-operating items, interest, and income taxes are classified based on issuer disclosures and XBRL tagging.

Source & verification

  • Source: SEC 10-Q filings
  • Filed with the SEC: November 4, 2025
  • Original filing: fold-20250930.htm

Income statement figures represent operating results for each reporting period and may be revised in subsequent filings.